IVO 250 Pill - blue oval, 18mm
Generic Name: ivosidenib
Pill with imprint IVO 250 is Blue, Oval and has been identified as Tibsovo 250 mg. It is supplied by Agios Pharmaceuticals, Inc.
Tibsovo is used in the treatment of Biliary Tract Tumor; Acute Myeloid Leukemia; Myelodysplastic Syndrome and belongs to the drug class miscellaneous antineoplastics. Tibsovo 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IVO 250
Tibsovo
- Generic Name
- ivosidenib
- Imprint
- IVO 250
- Strength
- 250 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Agios Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71334-0100
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Revuforj
Revuforj is used to treat acute leukemia with a lysine methyltransferase 2A gene translocation ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Inqovi
Inqovi (decitabine and cedazuridine) is used for the treatment of myelodysplastic syndromes (MDS) ...
More about Tibsovo (ivosidenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.